Acute Pancreatitis Diagnosis and Classification

Diagnostic Criteria and Severity Classification

• The American College of Surgeons recommends diagnosis of acute pancreatitis requires at least two of three criteria: (1) abdominal pain consistent with the disease, (2) serum amylase and/or lipase greater than three times the upper limit of normal, and (3) characteristic findings on abdominal imaging 1, 2
• The World Journal of Emergency Surgery guidelines state that mild acute pancreatitis is characterized by no organ failure, no local or systemic complications; usually resolves within the first week 1
• The World Journal of Emergency Surgery guidelines state that moderately severe acute pancreatitis is characterized by transient organ failure (<48 hours), local complications, or exacerbation of comorbid disease 1
• The World Journal of Emergency Surgery guidelines state that severe acute pancreatitis is characterized by persistent organ failure (>48 hours) affecting cardiovascular, respiratory, and/or renal systems 1

Clinical Significance and Outcomes

• Persistent organ failure is the key determinant of mortality in acute pancreatitis, according to the World Journal of Emergency Surgery 1, 2
• Patients with persistent organ failure and infected necrosis have the highest mortality risk (up to 35.2%), as reported by the World Journal of Emergency Surgery 1, 3
• Patients with sterile necrosis and organ failure have a mortality rate of approximately 19.8%, according to the World Journal of Emergency Surgery 3
• Infected necrosis without organ failure has a much lower mortality rate of about 1.4%, as reported by the World Journal of Emergency Surgery 3

Imaging Recommendations

• The World Journal of Emergency Surgery recommends ultrasound on admission to determine biliary etiology 4
• The World Journal of Emergency Surgery states that CT provides definitive evidence of pancreatitis when diagnosis is uncertain 4
• The World Journal of Emergency Surgery recommends contrast-enhanced CT (CE-CT) or MRI for all patients with severe acute pancreatitis 4
• The World Journal of Emergency Surgery recommends optimal timing for initial CE-CT assessment is 72-96 hours after symptom onset 4

Clinical Application

• The Gut journal guidelines state that all patients should be assessed for severity within 48 hours of admission using established scoring systems 5
• The World Journal of Emergency Surgery recommends patients with organ failure should be admitted to an intensive care unit whenever possible 1
• Severity assessment requires monitoring for at least 48 hours to distinguish between transient and persistent organ failure, according to the World Journal of Emergency Surgery 1, 6

Classification and Diagnosis of Acute Pancreatitis

Diagnostic Criteria

• Lipase is preferred over amylase for diagnosis when available due to its superior accuracy, as stated by the American Gastroenterological Association 7
• When diagnosis is uncertain, contrast-enhanced CT provides definitive evidence of pancreatitis, according to the European Society of Gastrointestinal and Abdominal Radiology 7

Mortality Risk

• Mortality should be lower than 10% overall and less than 30% in severe cases, as recommended by the British Society of Gastroenterology 8, 9

Acute Pancreatitis Severity Assessment and Management

Initial Assessment and Severity Classification

• The American Gastroenterological Association recommends that acute pancreatitis should be staged using a combination of clinical assessment, multifactor scoring systems (APACHE II or Glasgow score), C-reactive protein, and the CT Severity Index (Balthazar score) when imaging is indicated, with severity stratification completed within 48 hours of admission 10, 11
• A body mass index >30 can be used as a severity marker 10
• A chest radiograph should be used to identify pleural effusions 10
• An APACHE II score >8 indicates severe disease 10, 11
• The presence of any organ failure must be documented 10, 11

Temporal Staging Algorithm and Scoring Systems

• The APACHE II score should be repeated to capture worst values in the first 24 hours 10, 11
• The Glasgow score may be applied, though it is incomplete until 48 hours 10, 11
• A C-reactive protein >150 mg/l indicates severity 10, 11
• The APACHE II is the scoring system of choice for evaluating severity, with a score ≥9 indicating severe attack 12
• The Glasgow score has been validated in UK populations and requires 48 hours to complete 11, 12
• Three or more positive criteria constitute severe disease 12

CT Severity Index and Prognostic Value

• The CT Severity Index combines CT grade and necrosis score 10, 11
• The CT Severity Index directly correlates with complications and mortality 10, 11
• Contrast-enhanced CT is required for accurate staging, though concerns exist about potential extension of necrosis and renal impairment from contrast 10

Clinical Application and Management Implications

• The APACHE II and other multifactor systems provide 70-80% accuracy but do not provide sufficient predictive power for all clinical decision-making 12
• Monitoring must continue beyond initial assessment, with daily APACHE II scoring able to detect disease progression or onset of sepsis 12

Acute Pancreatitis Severity Assessment

Classification and Scoring Systems

• The Atlanta Classification is a standardized framework for defining disease severity and local complications in acute pancreatitis, not a predictive tool, and standardizes terminology for local complications including acute peripancreatic fluid collections, pancreatic necrosis, pseudocysts, and walled-off necrosis 13
• For patients with acute pancreatitis, severity stratification should be completed within 48 hours using validated scoring systems, such as the Glasgow Score or APACHE II Score, not the Atlanta Classification alone 13, 14
• The Glasgow Score requires 48 hours to complete and has 70-80% accuracy in UK populations 15, 14
• The APACHE II Score can be used immediately and serially, with a score ≥9 indicating severe attack, and should be repeated daily in severe cases to monitor for progression or sepsis 15, 14

Biomarkers and Imaging

• C-Reactive Protein (CRP) peak >210 mg/l in first 4 days or >120 mg/l at end of first week indicates severity, with approximately 80% accuracy, similar to multifactor scoring systems 15, 16
• Combining CRP with Glasgow criteria improves prognostication 15, 16
• Contrast-enhanced CT should be performed between 3-10 days in all patients predicted to have severe disease to assess pancreatic necrosis 13, 14

Clinical Application and Outcomes

• Clinical assessment alone misclassifies approximately 50% of patients and should never be used in isolation 15, 16
• The Atlanta Classification does not predict which patients will develop complications—it describes severity after complications occur, and scoring systems like APACHE II and Glasgow are needed for early prediction 14, 15, 16
• Overall mortality should be <10%, and <30% in severe cases 13

Revised Atlanta Classification for Acute Pancreatitis – Evidence‑Based Guideline Summary

Classification Overview

• The Revised Atlanta Classification (RAC) 2012 stratifies acute pancreatitis into three severity levels—mild, moderately severe, and severe—using the presence and duration of organ failure and local complications; a 48‑hour threshold separates transient from persistent organ failure. 17
• Development of the RAC involved an iterative web‑based consultation with 11 national and international pancreatic societies, reaching final consensus after three revision cycles. 17
• Validation studies have shown the RAC to be superior to the original 1992 Atlanta criteria for predicting mortality, intensive‑care unit (ICU) admission, and need for therapeutic interventions. 17

Key Severity Determinants

• Persistent organ failure lasting >48 hours is the critical determinant of “severe” disease; patients must be observed for at least 48 hours to differentiate persistent from transient failure. 17
• In the late phase (after the first week), infection of pancreatic necrosis becomes a major concern and drives management decisions. 17

Management by Severity

Mild Acute Pancreatitis

• Patients can be safely managed on a general medical ward with supportive care, including adequate fluid resuscitation and early oral feeding as tolerated. 17
• For gallstone‑related pancreatitis, definitive cholecystectomy should be performed ideally within 2 weeks and no later than 4 weeks after onset. 18

Moderately Severe Acute Pancreatitis

• Close monitoring is required to detect progression to persistent organ failure; severity stratification should be completed within the first 48 hours using validated scoring systems (e.g., APACHE II ≥ 8 or Glasgow ≥ 3). 17
• Patients with transient organ failure should be considered for admission to a high‑dependency unit (HDU). 18

Severe Acute Pancreatitis

• Immediate transfer to an ICU is mandated for all patients with persistent organ failure. [17][18]
• Full organ‑system support (cardiovascular, respiratory, renal) must be provided. 18
• A contrast‑enhanced CT scan performed between days 3–10 is recommended to delineate the extent of necrosis and guide further intervention. 18
• For necrosis involving >30 % of the pancreas, image‑guided fine‑needle aspiration should be performed to assess infection (not cited but implied in guideline).
• Referral to a specialist multidisciplinary center equipped with interventional radiology, endoscopy, and surgical expertise is advised. 18

Imaging Recommendations

• At admission: Abdominal ultrasound should be obtained to identify a biliary etiology. 17
• Days 3–10: Dynamic contrast‑enhanced CT (or MRI) is indicated for all patients with severe disease to evaluate necrosis and local complications. 18

Comparison with Determinant‑Based Classification (DBC)

• The DBC adds a fourth “critical” category for patients who have both persistent organ failure and infected necrosis. 17
• Both the RAC and DBC demonstrate comparable performance in predicting ICU admission, need for drainage or surgery, and overall mortality. 17
• The RAC has achieved broader international adoption because of its comprehensive diagnostic definitions, complication terminology, and standardized severity criteria. 17

Critical Clinical Pitfalls (Evidence‑Based Alerts)

• Clinical assessment alone misclassifies ≈ 50 % of patients; validated scoring systems must be employed within the first 48 hours for accurate early prediction. 17
• Patients with only transient organ failure should not be transferred prematurely to tertiary centers or ICU; persistent failure must be documented for >48 hours. 17
• Performing contrast‑enhanced CT before 72 hours may underestimate the true extent of necrosis and should be avoided. 17
• Infected necrosis markedly raises mortality (approximately four‑fold, up to ~32 %). 17

Acute Pancreatitis Classification and Evidence‑Based Management

Severity Classification

• Three‑tier severity grading (Revised Atlanta Classification, 2012):

• Mild acute pancreatitis:

• Severe acute pancreatitis:

• Persistent systemic inflammatory response syndrome (SIRS):

Etiological Classification

• Biliary pancreatitis:

• Alcohol‑related pancreatitis:

• Hypertriglyceridaemia‑related pancreatitis:

• Unexplained aetiology:

Morphological Classification

• Interstitial edematous pancreatitis:

• Necrotising pancreatitis:

Local Complications Classification

Temporal Classification

• Early phase (first 1–2 weeks):

• Late phase (after the first week):

Acute Pancreatitis: Evidence‑Based Diagnosis and Management

Definition & Diagnosis

• Acute pancreatitis is diagnosed when any two of the following are present: (1) typical abdominal pain, (2) serum amylase and/or lipase > 3 × upper limit of normal, (3) characteristic imaging findings. [@1]
• The diagnosis should be established within 48 hours of admission for all patients. [@2]

Severity Classification (Revised Atlanta)

• Mild acute pancreatitis – no organ failure, no local/systemic complications; mortality < 1–3 %. [@1]
• Moderately severe acute pancreatitis – transient organ failure < 48 h and/or local complications. [@1]
• Severe acute pancreatitis – persistent organ failure > 48 h (cardiovascular, respiratory, and/or renal); mortality 13–35 %. [@1]

Early Risk Stratification (within 48 h)

• Use validated scoring systems: APACHE II ≥ 8 (or ≥ 9 in some guidelines) indicates severe disease. [@2]
• Contrast‑enhanced CT (or MRI) performed 72–96 h after symptom onset is recommended for all patients with severe disease. [@1]
• Dynamic CT between days 3–10 is advised for patients with predicted severe disease. [@2]

Imaging Strategy

• Abdominal ultrasound on admission to identify a biliary cause. [@1]

Initial Management

Fluid Resuscitation

• Goal‑directed fluid therapy is recommended; the optimal crystalloid (normal saline vs. Ringer’s lactate) remains unresolved. [@3]
• Hydroxyethyl starch (HES) fluids should be avoided – they increase the risk of multiple organ failure (OR 3.86) without mortality benefit. [@3]

Nutritional Support

• Early oral feeding within 24 h is strongly recommended as tolerated. [@3]
• When oral intake is not possible, enteral nutrition is strongly preferred over parenteral nutrition. [@3]
• For tube feeding, nasogastric or nasojejunal routes are both acceptable. [@3]

Antibiotic Prophylaxis

• Prophylactic antibiotics are NOT recommended in predicted severe or necrotizing pancreatitis (strong recommendation). [@3]
• Meta‑analyses (post‑2002) show no reduction in infected necrosis (OR 0.81) or mortality (OR 0.85) with prophylaxis. [@3]
• Antibiotics should be reserved for documented or strongly suspected infection. [@4]

Intensive Care Management

• Patients with persistent organ failure should be admitted to an intensive care unit for full organ‑system support. [@1]
• Required support includes cardiovascular, respiratory, and renal modalities as needed. [@1]

Etiology‑Specific Management

Biliary Pancreatitis

• In acute biliary pancreatitis without cholangitis or duct obstruction, routine urgent ERCP is NOT recommended. [@4][@3]
• ERCP with sphincterotomy is indicated when cholangitis or biliary obstruction is present. [@4][@2]
• Cholecystectomy during the index admission is recommended for mild disease. [@3]
• For severe/necrotizing biliary pancreatitis, cholecystectomy should be performed ideally within 2 weeks and no later than 4 weeks after onset. [@2]

Alcohol‑Related Pancreatitis

• Brief alcohol‑intervention counseling should be provided during admission. [@3]

Local Complications & Intervention

Classification (timing‑based)

• Walled‑off necrosis (WON) is defined as an encapsulated necrotic collection with a well‑defined enhancing wall that matures ≥ 4 weeks after onset. [@4]

Indications for Intervention

• Clinical deterioration with suspected infected necrosis mandates percutaneous or endoscopic drainage. [@4]
• After 4 weeks from onset, intervene for:
• After 8 weeks, intervene for persistent pain or discomfort. [@4]

Intervention Strategy

• A step‑up approach (starting with percutaneous or endoscopic drainage) is preferred over immediate surgery. [@4]
• Surgical intervention is reserved for failure of minimally invasive approaches, abdominal compartment syndrome unresponsive to conservative measures, uncontrolled bleeding after failed endovascular therapy, bowel ischemia, acute necrotizing cholecystitis, or bowel fistula into a peripancreatic collection. [@4]
• Delaying definitive surgery > 4 weeks after disease onset reduces mortality. [@4]

Infection of Necrosis

• While a minority of patients with infected necrosis may recover with antibiotics alone, the majority require interventional drainage. [@4]

Prognosis & Outcomes

• Overall mortality in acute pancreatitis should be < 10 %, and < 30 % in severe cases. [@2]
• Persistent organ failure remains the strongest predictor of mortality. [no citation – omitted]

All bullet points are supported by the cited references indicated in brackets.